Trials / Completed
CompletedNCT02858024
A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine
A Two-Cohort, Open-Label, Randomised, Three-Period Crossover Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- International Partnership for Microbicides, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A Two-Cohort, Open-Label, Randomised, Three-Period Crossover Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dapivirine Vaginal Ring-004 and no tampons | Dapivirine Vaginal Ring-004 for 28 days, with menses, no tampon use (Treatment A), |
| DRUG | Dapivirine Vaginal Ring-004 with tampons | followed by Dapivirine Vaginal Ring-004 for 28 days, with menses, with tampon use (Treatment B) |
| DRUG | Dapivirine Vaginal Ring-004 with no menses | Dapivirine Vaginal Ring-004 for 28 days, with no menses occurring (Treatment E; treatment period 3). |
| DRUG | Dapivirine Vaginal Ring-004 and same ring inserted after menses | Dapivirine Vaginal Ring-004 used continuously until the start of menses, at which time the ring will be removed, and the same ring re-inserted five days later (estimated completion of menses) (Treatment C) |
| DRUG | Dapivirine Vaginal Ring-004 and new ring inserted after menses | Dapivirine Vaginal Ring-004 used continuously until the start of menses, at which time the ring will be removed, and a new ring inserted five days later (estimated completion of menses) (Treatment D) |
Timeline
- Start date
- 2015-01-12
- Primary completion
- 2016-04-16
- Completion
- 2016-04-16
- First posted
- 2016-08-08
- Last updated
- 2017-09-06
Source: ClinicalTrials.gov record NCT02858024. Inclusion in this directory is not an endorsement.